Shared on 04 Nov 25
Analysts have recently lifted their price targets for Rolls-Royce Holdings, with expectations rising from £10.40 to £12.45 and as high as £12.90 per share. This reflects increased confidence in the company's ability to deliver capital returns amid strong European aerospace market demand and an improving aftermarket outlook.
Shared on 21 Oct 25
Fair value Increased 5.02%Analysts Lift Rolls-Royce Targets Amid Stronger Outlook and Improved Fundamentals
Analysts have raised their price target for Rolls-Royce Holdings from £11.36 to £11.93. They cite strengthening fundamentals and improved industry outlooks as key drivers for this positive revision.
Shared on 30 Aug 25
Fair value Increased 3.68%Rising Supply Chain Risks And Slowing Demand Will Undercut Margins
Analysts have raised their price target for Rolls-Royce Holdings to £11.19, citing improved fundamentals, robust aerospace demand, stronger cash flow, and enhanced profitability, though some caution about valuation after recent gains. Analyst Commentary Bullish analysts have increased price targets based on improving company fundamentals and sustained earnings momentum.
Shared on 06 Aug 25
Fair value Increased 23%Rising Supply Chain Risks And Slowing Demand Will Undercut Margins
Analysts have raised their price target for Rolls-Royce Holdings to £9.97, citing stronger cash flow forecasts, sustained operational improvements, and a more optimistic long-term aerospace outlook. Analyst Commentary Valuation concerns leading to a more cautious outlook after strong share price appreciation.
Shared on 29 Jul 25
Fair value Increased 13%Regulatory Delays In SMR Projects Will Escalate Costs And Reduce Returns
Analysts have raised their price targets for Rolls-Royce Holdings due to strong earnings momentum, improving operational performance, margin improvement, and a better outlook for aerospace and defense, resulting in the consensus analyst price target increasing from £7.91 to £8.90. Analyst Commentary Valuation concerns driving downgrades from some analysts after the recent share price rally.
Shared on 19 Mar 25
Fair value Increased 0.0075%Regulatory Delays In SMR Projects Will Escalate Costs And Reduce Returns
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 12 Mar 25
Fair value Decreased 11%Regulatory Delays In SMR Projects Will Escalate Costs And Reduce Returns
AnalystConsensusTarget has increased revenue growth from 4.7% to 5.2% and increased future PE multiple from 31.0x to 34.6x.

